Somani, Bhaskar
Emiliani, Esteban
Knoll, Thomas
Mandrile, Giorgia
Rumsby, Gill
Acquaviva, Cecile
Bhojani, Naeem
Bin Hamri, Saeed
Bres-Niewada, Ewa
Davis, Niall F.
Fuster, Daniel G.
Garrelfs, Sander F.
Gauhar, Vineet
Hamamoto, Shuzo
Juliebø-Jones, Patrick
Leporati, Marta
Letavernier, Emmanuel
Takayama, Tatsuya
Tzelves, Lazaros
Yuen, Steffi Kar Kei
Ferraro, Pietro Manuel
Article History
Received: 14 February 2025
Accepted: 26 March 2025
First Online: 22 April 2025
Declarations
:
: Author disclosures are the following: BS, EE, GR, and SG received consultation fees from Novo Nordisk. PMF received consultation fees and grant/other support from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, Bayer, Gilead, Novo Nordisk, Otsuka Pharmaceuticals, Rocchetta, Vifor Fresenius, and royalties as an author for UpToDate. GM is a Medical Advisor for Alnylam and Novo Nordisk, received funding for independent research projects from Novo Nordisk and is a Principal Investigator in the Alnylam Bonaph1 de Phase 4 study. TK has received consultation fees from Karl Storz Endoscopes, Quanta System, Cook Medical and Electro Medical System. EL received consulting fees from Biocodex, AskBio and Inflectis. NB has received consultation fees for Boston Scientific, Olympus and Procept Biorobotics. SH has received consultation fees from Boston Scientific and Olympus. The other authors declare no competing interests.
: Not applicable.
: Not applicable.